Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH

RT @DocCatenacci: @pashtoonkasi @ASCO_pubs @ASCO @PTarantinoMD @BenWestphalen @agrothey @marklewismd @DrSGraff @tmprowell @DrKelseyKlute @O…

@pashtoonkasi @ASCO_pubs @ASCO @PTarantinoMD @BenWestphalen @agrothey @marklewismd @DrSGraff @tmprowell @DrKelseyKlute @OncoAlert See also this paper👇🏻 https://t.co/Rtcc85PEpD

RT @DocCatenacci: @antonyruggeri @pashtoonkasi @LFerri123 Good question. 1) In the absence of amplification IHC 3+ is relatively rare for o…

RT @DocCatenacci: @pashtoonkasi @LFerri123 “You can have the gene but not express protein?” Generally not, As Gene copy number drops protei…

@antonyruggeri @pashtoonkasi @LFerri123 Good question. 1) In the absence of amplification IHC 3+ is relatively rare for one (see TOGA: <3% of all pts enrolled, only 5.5% of all enrolled IHC3+ tumors). 2) The expression of these FISH- tumors is actually

@pashtoonkasi @LFerri123 “You can have the gene but not express protein?” Generally not, As Gene copy number drops protein expression drops concordantly: https://t.co/Rtcc85PEpD

Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison… https://t.co/tZizwFNavw https://t.co/mQuTxUsmzw